{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:11:14Z","timestamp":1793121074553,"version":"4.5.0"},"reference-count":67,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":320,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016204","name":"Ministry of Higher Education, Science, Research and Innovation, Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016204","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014795","name":"Center of Excellence for Innovation in Chemistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2025,1,1]]},"DOI":"10.1016\/j.csbj.2025.11.039","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:57:56Z","timestamp":1763639876000},"page":"5271-5280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["LC-MS\/MS identifies elevated imidazole propionate and gut-derived metabolite alterations in peritoneal dialysis patients"],"prefix":"10.34133","volume":"27","author":[{"given":"Weerawan","family":"Manokasemsan","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Thailand Metabolomics Association, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumol","family":"Jariyasopit","sequence":"additional","affiliation":[{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Thailand Metabolomics Association, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwanjeera","family":"Wanichthanarak","sequence":"additional","affiliation":[{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcha","family":"Poungsombat","sequence":"additional","affiliation":[{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Thailand Metabolomics Association, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alongkorn","family":"Kurilung","sequence":"additional","affiliation":[{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphitcha","family":"Limjiasahapong","sequence":"additional","affiliation":[{"name":"Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Thailand Metabolomics Association, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajol","family":"Thapa","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyut","family":"Sirivatanauksorn","sequence":"additional","affiliation":[{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Thailand Metabolomics Association, Bangkok, Thailand"},{"name":"Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukit","family":"Raksasuk","sequence":"additional","affiliation":[{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thatsaphan","family":"Srithongkul","sequence":"additional","affiliation":[{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chagriya","family":"Kitiyakara","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakda","family":"Khoomrung","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Center of Research Excellent in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Thailand Metabolomics Association, Bangkok, Thailand"},{"name":"Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"e_1_3_6_2_2","unstructured":"System-NIDDK USRD. 2024 Annual Data Report - End Stage Renal Disease: Chapter 11. NIH - National Institute of Diabetes and Digestive and Kidney Disease (NIDDK): United States Renal Data System (USRDS). End Stage Renal Disease: Chapter 1 - Incidence Prevalence Patient Characteristics and Treatment Modalities Web site. \u3008https:\/\/usrds-adr.niddk.nih.gov\/2024\/end-stage-renal-disease\/11-international-comparisons\u3009. Published 2024. Accessed January 26 2025."},{"key":"e_1_3_6_3_2","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMra2100152","article-title":"Peritoneal dialysis","volume":"385","author":"Teitelbaum I.","year":"2021","unstructured":"Teitelbaum I.: Peritoneal dialysis. N Engl J Med 2021; 385: 1786.","journal-title":"N Engl J Med"},{"key":"e_1_3_6_4_2","first-page":"S153","article-title":"The \"PD First\" policy in Thailand: three-years experiences (2008-2011)","volume":"94","author":"Dhanakijcharoen P.","year":"2011","unstructured":"Dhanakijcharoen P., Sirivongs D., Aruyapitipan S., Chuengsaman P. and Lumpaopong A.: The \"PD First\" policy in Thailand: three-years experiences (2008-2011). J Med Assoc Thai 2011; 94: S153.","journal-title":"J Med Assoc Thai"},{"key":"e_1_3_6_5_2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","article-title":"Epidemiology of peritoneal dialysis outcomes","volume":"18","author":"Bello A.K.","year":"2022","unstructured":"Bello A.K., Okpechi I.G., Osman M.A. et al: Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol 2022; 18: 779.","journal-title":"Nat Rev Nephrol"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2021.09.007"},{"key":"e_1_3_6_7_2","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.639624","article-title":"Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients","volume":"12","author":"Bao M.","year":"2022","unstructured":"Bao M., Zhang P., Guo S. et al: Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients. Front Cell Infect Microbiol 2022; 12: 639624.","journal-title":"Front Cell Infect Microbiol"},{"key":"e_1_3_6_8_2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2013121283","article-title":"The cardiovascular effect of the uremic solute indole-3 acetic acid","volume":"26","author":"Dou L.","year":"2015","unstructured":"Dou L., Sall\u00e9e M., Cerini C. et al: The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol 2015; 26: 876.","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_6_9_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.jrn.2014.10.010","article-title":"Uremic toxins, oxidative stress, and renal fibrosis: an interwined complex","volume":"25","author":"Chao C.T.","year":"2015","unstructured":"Chao C.T. and Chiang C.K.: Uremic toxins, oxidative stress, and renal fibrosis: an interwined complex. J Ren Nutr 2015; 25: 155.","journal-title":"J Ren Nutr"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.345"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013080905"},{"key":"e_1_3_6_12_2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","article-title":"Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease","volume":"97","author":"Gryp T.","year":"2020","unstructured":"Gryp T., De Paepe K., Vanholder R. et al: Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Kidney Int 2020; 97: 1230.","journal-title":"Kidney Int"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319766"},{"key":"e_1_3_6_14_2","doi-asserted-by":"crossref","DOI":"10.1038\/srep14381","article-title":"Continuous reduction of protein-bound uraemic toxins with improved oxidative stress by using the oral charcoal adsorbent AST-120 in haemodialysis patients","volume":"5","author":"Yamamoto S.","year":"2015","unstructured":"Yamamoto S., Kazama J.J., Omori K. et al: Continuous reduction of protein-bound uraemic toxins with improved oxidative stress by using the oral charcoal adsorbent AST-120 in haemodialysis patients. Sci Rep 2015; 5: 14381.","journal-title":"Sci Rep"},{"key":"e_1_3_6_15_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/aor.12961","article-title":"Adsorption of protein-bound uremic toxins through direct hemoperfusion with hexadecyl-immobilized cellulose beads in patients undergoing hemodialysis","volume":"42","author":"Yamamoto S.","year":"2018","unstructured":"Yamamoto S., Sato M., Sato Y. et al: Adsorption of protein-bound uremic toxins through direct hemoperfusion with hexadecyl-immobilized cellulose beads in patients undergoing hemodialysis. Artif Organs 2018; 42: 88.","journal-title":"Artif Organs"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09735-4"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.055"},{"key":"e_1_3_6_18_2","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1038\/s41467-020-19589-w","article-title":"Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology","volume":"11","author":"Molinaro A.","year":"2020","unstructured":"Molinaro A., Bel Lassen P., Henricsson M. et al: Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nat Commun 2020; 11: 5881.","journal-title":"Nat Commun"},{"key":"e_1_3_6_19_2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jchf.2023.03.008","article-title":"Microbially produced imidazole propionate is associated with heart failure and mortality","volume":"11","author":"Molinaro A.","year":"2023","unstructured":"Molinaro A., Nemet I., Bel Lassen P. et al: Microbially produced imidazole propionate is associated with heart failure and mortality. JACC Heart Fail 2023; 11: 810.","journal-title":"JACC Heart Fail"},{"key":"e_1_3_6_20_2","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1038\/s41598-025-87416-7","article-title":"Joint association of TyG index and LDL-C with all-cause and cardiovascular mortality among patients with cardio-renal-metabolic disease","volume":"15","author":"Lai W.","year":"2025","unstructured":"Lai W., Lin Y., Gao Z., Huang Z. and Zhang T.: Joint association of TyG index and LDL-C with all-cause and cardiovascular mortality among patients with cardio-renal-metabolic disease. Sci Rep 2025; 15: 5854.","journal-title":"Sci Rep"},{"key":"e_1_3_6_21_2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41440-022-01114-9","article-title":"The public health impact of hypertension and diabetes: a powerful tag team for the development of chronic kidney disease","volume":"46","author":"Kohagura K.","year":"2023","unstructured":"Kohagura K.: The public health impact of hypertension and diabetes: a powerful tag team for the development of chronic kidney disease. Hypertens Res 2023; 46: 339.","journal-title":"Hypertens Res"},{"key":"e_1_3_6_22_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","article-title":"Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy","volume":"9","author":"Lu X.","year":"2024","unstructured":"Lu X., Xie Q., Pan X. et al: Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther 2024; 9: 262.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_6_23_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/db20211-13","article-title":"The interplay between diabetes, cardiovascular disease, and kidney disease","volume":"2021","author":"Usman M.S.","year":"2021","unstructured":"Usman M.S., Khan M.S. and Butler J.: The interplay between diabetes, cardiovascular disease, and kidney disease. Compendia 2021; 2021: 13.","journal-title":"Compendia"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R500013-JLR200"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.01.021"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2023.09.032"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116375"},{"key":"e_1_3_6_28_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122511","article-title":"A targeted ultra performance liquid chromatography \u2013 Tandem mass spectrometric assay for tyrosine and metabolites in urine and plasma: application to the effects of antibiotics on mice","volume":"1164","author":"Letertre M.P.M.","year":"2021","unstructured":"Letertre M.P.M., Myridakis A., Whiley L. et al: A targeted ultra performance liquid chromatography \u2013 Tandem mass spectrometric assay for tyrosine and metabolites in urine and plasma: application to the effects of antibiotics on mice. J Chromatogr B 2021; 1164: 122511.","journal-title":"J Chromatogr B"},{"key":"e_1_3_6_29_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113551","article-title":"An LC-MS\/MS analytical method for the determination of uremic toxins in patients with end-stage renal disease","volume":"191","author":"Ma Y.R.","year":"2020","unstructured":"Ma Y.R., Xin M.Y., Li K. et al: An LC-MS\/MS analytical method for the determination of uremic toxins in patients with end-stage renal disease. J Pharm Biomed Anal 2020; 191: 113551.","journal-title":"J Pharm Biomed Anal"},{"key":"e_1_3_6_30_2","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1038\/s41598-021-84694-9","article-title":"Combined LC-MS\/MS and 16S rDNA analysis on mice under high temperature and humidity and Herb Yinchen protection mechanism","volume":"11","author":"Wang Y.","year":"2021","unstructured":"Wang Y., Chen J., Tang J. et al: Combined LC-MS\/MS and 16S rDNA analysis on mice under high temperature and humidity and Herb Yinchen protection mechanism. Sci Rep 2021; 11: 5099.","journal-title":"Sci Rep"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-016-0048-1"},{"key":"e_1_3_6_32_2","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10070282","article-title":"Development and validation of a highly sensitive LC-MS\/MS method for the analysis of bile acids in serum, plasma, and liver tissue samples","volume":"10","author":"Gomez C.","year":"2020","unstructured":"Gomez C., Stucheli S., Kratschmar D.V., Bouitbir J. and Odermatt A.: Development and validation of a highly sensitive LC-MS\/MS method for the analysis of bile acids in serum, plasma, and liver tissue samples. Metabolites 2020; 10.","journal-title":"Metabolites"},{"key":"e_1_3_6_33_2","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24279","article-title":"A simple and reliable bile acid assay in human serum by LC-MS\/MS","volume":"36","author":"Shen Y.","year":"2022","unstructured":"Shen Y., Liu K., Luo X., Guan Q. and Cheng L.: A simple and reliable bile acid assay in human serum by LC-MS\/MS. J Clin Lab Anal 2022; 36: e24279.","journal-title":"J Clin Lab Anal"},{"key":"e_1_3_6_34_2","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.1021\/acs.jafc.1c03433","article-title":"Targeted LC-MS\/MS profiling of bile acids in various animal tissues","volume":"69","author":"Reiter S.","year":"2021","unstructured":"Reiter S., Dunkel A., Dawid C. and Hofmann T.: Targeted LC-MS\/MS profiling of bile acids in various animal tissues. J Agric Food Chem 2021; 69: 10572.","journal-title":"J Agric Food Chem"},{"key":"e_1_3_6_35_2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-2275(20)32342-7","article-title":"Determination of bile acids in biological fluids by liquid chromatography-electrospray tandem mass spectrometry","volume":"42","author":"Perwaiz S.","year":"2001","unstructured":"Perwaiz S., Tuchweber B., Mignault D., Gilat T. and Yousef I.M.: Determination of bile acids in biological fluids by liquid chromatography-electrospray tandem mass spectrometry. J Lipid Res 2001; 42: 114.","journal-title":"J Lipid Res"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2024.05.007"},{"key":"e_1_3_6_37_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.12.011","article-title":"Measurement of very low-molecular weight metabolites by traveling wave ion mobility and its use in human urine samples","volume":"14","author":"Kurilung A.","year":"2024","unstructured":"Kurilung A., Limjiasahapong S., Kaewnarin K. et al: Measurement of very low-molecular weight metabolites by traveling wave ion mobility and its use in human urine samples. J Pharm Anal 2024; 14: 100921.","journal-title":"J Pharm Anal"},{"key":"e_1_3_6_38_2","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1021\/ac3032405","article-title":"Rapid quantification of yeast lipid using microwave-assisted total lipid extraction and HPLC-CAD","volume":"85","author":"Khoomrung S.","year":"2013","unstructured":"Khoomrung S., Chumnanpuen P., Jansa-Ard S. et al: Rapid quantification of yeast lipid using microwave-assisted total lipid extraction and HPLC-CAD. Anal Chem 2013; 85: 4912.","journal-title":"Anal Chem"},{"key":"e_1_3_6_39_2","unstructured":"Association of Official Analytical Chemists Appendix F: Guidelines for Standard Method Performance Requirements. \u3008https:\/\/www.aoac.org\/wp-content\/uploads\/2019\/08\/app_f.pdf\u3009. Accessed May 10 2024."},{"key":"e_1_3_6_40_2","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2020.602993","article-title":"UPLC-ESI-MRM\/MS for absolute quantification and MS\/MS structural elucidation of six specialized pyranonaphthoquinone metabolites from ventilago harmandiana","volume":"11","author":"Limjiasahapong S.","year":"2020","unstructured":"Limjiasahapong S., Kaewnarin K., Jariyasopit N. et al: UPLC-ESI-MRM\/MS for absolute quantification and MS\/MS structural elucidation of six specialized pyranonaphthoquinone metabolites from ventilago harmandiana. Front Plant Sci 2020; 11: 602993.","journal-title":"Front Plant Sci"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-012-0434-4"},{"key":"e_1_3_6_42_2","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giae005","article-title":"Data processing solutions to render metabolomics more quantitative: case studies in food and clinical metabolomics using Metabox 2.0","volume":"13","author":"Wanichthanarak K.","year":"2024","unstructured":"Wanichthanarak K., In-On A., Fan S., Fiehn O., Wangwiwatsin A. and Khoomrung S.: Data processing solutions to render metabolomics more quantitative: case studies in food and clinical metabolomics using Metabox 2.0. Gigascience 2024; 13.","journal-title":"Gigascience"},{"key":"e_1_3_6_43_2","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28217405","article-title":"Development and validation of LC-MS\/MS method for the determination of 1-methyl-4-nitrosopiperazine (MNP) in multicomponent products with rifampicin-analytical challenges and degradation studies","volume":"28","author":"Witkowska A.B.","year":"2023","unstructured":"Witkowska A.B., Wolczynska A., Lis-Cieplak A. and Stolarczyk E.U.: Development and validation of LC-MS\/MS method for the determination of 1-methyl-4-nitrosopiperazine (MNP) in multicomponent products with rifampicin-analytical challenges and degradation studies. Molecules 2023; 28.","journal-title":"Molecules"},{"key":"e_1_3_6_44_2","unstructured":"Quality FADAOORA. ORA Lab Manual Vol. II - Methods Method Verification and Validation (ORALAB.5.4.5). QMS Standard Operating Procedure (SOP) Template Web site. \u3008https:\/\/www.fda.gov\/media\/73920\/download\u3009. Updated 31 Oct 2023. Accessed May 10 2024."},{"key":"e_1_3_6_45_2","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2215\/CJN.02940509","article-title":"p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients","volume":"4","author":"Meijers B.K.","year":"2009","unstructured":"Meijers B.K., De Loor H., Bammens B., Verbeke K., Vanrenterghem Y. and Evenepoel P.: p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 2009; 4: 1932.","journal-title":"Clin J Am Soc Nephrol"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013101062"},{"key":"e_1_3_6_47_2","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4985","article-title":"Rapid simultaneous determination of gut microbial phenylalanine, tyrosine, and tryptophan metabolites in rat serum, urine, and faeces using LC-MS\/MS and its application to a type 2 diabetes mellitus study","volume":"35","author":"Zou B.","year":"2021","unstructured":"Zou B., Sun Y., Xu Z. et al: Rapid simultaneous determination of gut microbial phenylalanine, tyrosine, and tryptophan metabolites in rat serum, urine, and faeces using LC-MS\/MS and its application to a type 2 diabetes mellitus study. Biomed Chromatogr 2021; 35: e4985.","journal-title":"Biomed Chromatogr"},{"key":"e_1_3_6_48_2","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.7150\/thno.41725","article-title":"Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease","volume":"10","author":"Wu I.W.","year":"2020","unstructured":"Wu I.W., Gao S.S., Chou H.C. et al: Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease. Theranostics 2020; 10: 5398.","journal-title":"Theranostics"},{"key":"e_1_3_6_49_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55600-1","article-title":"Comprehensive and semi-quantitative analysis of carboxyl-containing metabolites related to gut microbiota on chronic kidney disease using 2-picolylamine isotopic labeling LC-MS\/MS","volume":"9","author":"Kanemitsu Y.","year":"2019","unstructured":"Kanemitsu Y., Mishima E., Maekawa M. et al: Comprehensive and semi-quantitative analysis of carboxyl-containing metabolites related to gut microbiota on chronic kidney disease using 2-picolylamine isotopic labeling LC-MS\/MS. Sci Rep 2019; 9: 19075.","journal-title":"Sci Rep"},{"key":"e_1_3_6_50_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103355","article-title":"Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker","volume":"24","author":"Anekthanakul K.","year":"2021","unstructured":"Anekthanakul K., Manocheewa S., Chienwichai K. et al: Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker. iScience 2021; 24: 103355.","journal-title":"iScience"},{"key":"e_1_3_6_51_2","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/jasms.1c00175","article-title":"High-resolution QTOF-MRM for highly accurate identification and quantification of trace levels of triterpenoids in ganoderma lucidum mycelium","volume":"32","author":"Kaewnarin K.","year":"2021","unstructured":"Kaewnarin K., Limjiasahapong S., Jariyasopit N. et al: High-resolution QTOF-MRM for highly accurate identification and quantification of trace levels of triterpenoids in ganoderma lucidum mycelium. J Am Soc Mass Spectrom 2021; 32: 2451.","journal-title":"J Am Soc Mass Spectrom"},{"key":"e_1_3_6_52_2","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.3390\/ijms22126196","article-title":"Uremic toxins and their relation with oxidative stress induced in patients with CKD","volume":"22","author":"Pieniazek A.","year":"2021","unstructured":"Pieniazek A., Bernasinska-Slomczewska J. and Gwozdzinski L.: Uremic toxins and their relation with oxidative stress induced in patients with CKD. Int J Mol Sci 2021; 22: 6196.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_6_53_2","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1681\/ASN.2015121302","article-title":"Microbiota-derived phenylacetylglutamine associates with overall mortality and cardiovascular disease in patients with CKD","volume":"27","author":"Poesen R.","year":"2016","unstructured":"Poesen R., Claes K., Evenepoel P. et al: Microbiota-derived phenylacetylglutamine associates with overall mortality and cardiovascular disease in patients with CKD. J Am Soc Nephrol 2016; 27: 3479.","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_6_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14030176"},{"key":"e_1_3_6_55_2","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010106","article-title":"The kidney-gut-muscle axis in end-stage renal disease is similarly represented in older adults","volume":"12","author":"Lustgarten M.S.","year":"2019","unstructured":"Lustgarten M.S.: The kidney-gut-muscle axis in end-stage renal disease is similarly represented in older adults. Nutrients 2019; 12.","journal-title":"Nutrients"},{"key":"e_1_3_6_56_2","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2186685","article-title":"Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL)","volume":"15","author":"Peters B.A.","year":"2023","unstructured":"Peters B.A., Qi Q., Usyk M. et al: Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL). Gut Microbes 2023; 15: 2186685.","journal-title":"Gut Microbes"},{"key":"e_1_3_6_57_2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/biom14091153","article-title":"Diabetic kidney disease: contribution of phenyl sulfate derived from dietary tyrosine upon gut microbiota catabolism","volume":"14","author":"Liu H.","year":"2024","unstructured":"Liu H., Diep T.N., Wang Y., Wang Y. and Yan L.-J.: Diabetic kidney disease: contribution of phenyl sulfate derived from dietary tyrosine upon gut microbiota catabolism. Biomolecules 2024; 14: 1153.","journal-title":"Biomolecules"},{"key":"e_1_3_6_58_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193342","article-title":"Phenyl sulfate, indoxyl sulfate and p-cresyl sulfate decrease glutathione level to render cells vulnerable to oxidative stress in renal tubular cells","volume":"13","author":"Edamatsu T.","year":"2018","unstructured":"Edamatsu T., Fujieda A. and Itoh Y.: Phenyl sulfate, indoxyl sulfate and p-cresyl sulfate decrease glutathione level to render cells vulnerable to oxidative stress in renal tubular cells. PLoS One 2018; 13: e0193342.","journal-title":"PLoS One"},{"key":"e_1_3_6_59_2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00216-012-5929-3","article-title":"Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production","volume":"403","author":"Itoh Y.","year":"2012","unstructured":"Itoh Y., Ezawa A., Kikuchi K., Tsuruta Y. and Niwa T.: Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem 2012; 403: 1841.","journal-title":"Anal Bioanal Chem"},{"key":"e_1_3_6_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119703"},{"key":"e_1_3_6_61_2","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.124.322346","article-title":"Gut microbial metabolite imidazole propionate impairs endothelial cell function and promotes the development of atherosclerosis","author":"Nageswaran V.","year":"2025","unstructured":"Nageswaran V., Carreras A., Reinshagen L. et al: Gut microbial metabolite imidazole propionate impairs endothelial cell function and promotes the development of atherosclerosis. Arterioscler Thromb Vasc Biol 2025; .","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_6_62_2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-025-09263-w","article-title":"Imidazole propionate is a driver and therapeutic target in atherosclerosis","volume":"645","author":"Mastrangelo A.","year":"2025","unstructured":"Mastrangelo A., Robles-Vera I., Ma\u00f1anes D. et al: Imidazole propionate is a driver and therapeutic target in atherosclerosis. Nature 2025; 645: 254.","journal-title":"Nature"},{"key":"e_1_3_6_63_2","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1046\/j.1523-1755.2001.59780084.x","article-title":"Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure","volume":"59","author":"Jankowski J.","year":"2001","unstructured":"Jankowski J., Tepel M., Stephan N. et al: Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure. Kidney Int 2001; 59: S84.","journal-title":"Kidney Int"},{"key":"e_1_3_6_64_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S291348","article-title":"Slipping through the pores: hypoalbuminemia and albumin loss during hemodialysis","volume":"14","author":"Kalantar-Zadeh K.F.L.","year":"2021","unstructured":"Kalantar-Zadeh K.F.L., Bazzanella J., Mullon C. and Anger M.S.: Slipping through the pores: hypoalbuminemia and albumin loss during hemodialysis. Int J Nephrol Renov Dis 2021; 14: 11.","journal-title":"Int J Nephrol Renov Dis"},{"key":"e_1_3_6_65_2","doi-asserted-by":"crossref","first-page":"1465 e1411","DOI":"10.1016\/j.amjmed.2017.07.020","article-title":"Low albumin levels are associated with mortality risk in hospitalized patients","volume":"130","author":"Akirov A.","year":"2017","unstructured":"Akirov A., Masri-Iraqi H., Atamna A. and Shimon I.: Low albumin levels are associated with mortality risk in hospitalized patients. Am J Med 2017; 130: 1465 e1411.","journal-title":"Am J Med"},{"key":"e_1_3_6_66_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.maturitas.2015.02.009","article-title":"Serum albumin and health in older people: review and meta analysis","volume":"81","author":"Cabrerizo S.","year":"2015","unstructured":"Cabrerizo S., Cuadras D., Gomez-Busto F., Artaza-Artabe I., Marin-Ciancas F. and Malafarina V.: Serum albumin and health in older people: review and meta analysis. Maturitas 2015; 81: 17.","journal-title":"Maturitas"},{"key":"e_1_3_6_67_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ando.2020.02.005","article-title":"PTH and cardiovascular risk","volume":"82","author":"Gruson D.","year":"2021","unstructured":"Gruson D.: PTH and cardiovascular risk. Ann Endocrinol (Paris) 2021; 82: 149.","journal-title":"Ann Endocrinol (Paris)"},{"key":"e_1_3_6_68_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eprac.2021.09.005","article-title":"Association of serum parathyroid hormone levels with all-cause and cause-specific mortality among U.S. adults","volume":"28","author":"Kato H.","year":"2022","unstructured":"Kato H., Ito N., Makita N., Nangaku M., Leung A.M. and Inoue K.: Association of serum parathyroid hormone levels with all-cause and cause-specific mortality among U.S. adults. Endocr Pract 2022; 28: 70.","journal-title":"Endocr Pract"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025005082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025005082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2025.11.039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:37:00Z","timestamp":1775219820000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2025.11.039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":67,"alternative-id":["10.1016\/j.csbj.2025.11.039"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2025.11.039","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC-MS\/MS identifies elevated imidazole propionate and gut-derived metabolite alterations in peritoneal dialysis patients","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2025.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}